rdf:type |
|
lifeskim:mentions |
umls-concept:C0021708,
umls-concept:C0181090,
umls-concept:C0302614,
umls-concept:C0370003,
umls-concept:C0458827,
umls-concept:C0809949,
umls-concept:C1282910,
umls-concept:C1301820,
umls-concept:C1701940,
umls-concept:C1706050,
umls-concept:C1880496,
umls-concept:C2347026
|
pubmed:issue |
9
|
pubmed:dateCreated |
2009-8-19
|
pubmed:abstractText |
: Ventilator-associated pneumonia is associated with an increase in morbidity and mortality. The delay before adequate antibiotherapy is known to influence patients' outcome. We hypothesized that the results of upper airways samples performed at immediately intensive care unit admission could help the clinician to choose the adequate empiric antibiotherapy for a ventilator-associated pneumonia occurring during the first 5 days of intensive care unit admission.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1530-0293
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2559-63
|
pubmed:meshHeading |
pubmed-meshheading:19623054-Female,
pubmed-meshheading:19623054-Humans,
pubmed-meshheading:19623054-Intensive Care Units,
pubmed-meshheading:19623054-Male,
pubmed-meshheading:19623054-Middle Aged,
pubmed-meshheading:19623054-Mouth,
pubmed-meshheading:19623054-Nasal Cavity,
pubmed-meshheading:19623054-Patient Admission,
pubmed-meshheading:19623054-Pneumonia, Ventilator-Associated,
pubmed-meshheading:19623054-Prospective Studies
|
pubmed:year |
2009
|
pubmed:articleTitle |
Can bacteriological upper airway samples obtained at intensive care unit admission guide empiric antibiotherapy for ventilator-associated pneumonia?
|
pubmed:affiliation |
Department of Anesthesiology, Critical Care and SAMU, Lariboisière Hospital, University Paris 7, Paris, France. romain.pirracchio@lrb.aphp.fr
|
pubmed:publicationType |
Journal Article,
Comparative Study
|